Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database.
Mod Rheumatol. 2016 May;26(3):336-341. doi: 10.3109/14397595.2015.1101200. Epub 2015 Nov 7.
Mod Rheumatol. 2016.
PMID: 26418571
How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol.
Torrente-Segarra V, Fernandez Prada M, Expósito Moliner R, Garrido Puñal NP, Sánchez-Andrade Fernández A, Lamua Riazuelo JR, Olivé A, Tovar Beltrán JV; RENACER Study Group (REgistro NAcional CERtolizumab).
Torrente-Segarra V, et al. Among authors: exposito moliner r.
Rheumatol Int. 2019 Feb;39(2):395-398. doi: 10.1007/s00296-018-4205-z. Epub 2018 Nov 24.
Rheumatol Int. 2019.
PMID: 30474721
No abstract available.
Item in Clipboard
Cite
Cite